Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...
The leading Advanced Melanoma Companies such as OncoSec Medical, Immunocore, Sanofi, TILT Biotherapeutics, Novartis ...
placebo-controlled crossover design clinical trial (NCT06505239) of its dietary supplement product unbuzzd, investigating its effects on alcohol intoxication and alcohol metabolism. Results of data ...
Quantum BioPharma announced that it has completed a double-blind, randomized, placebo-controlled crossover design clinical trial of its dietary ...
placebo-controlled crossover design clinical trial (NCT06505239) of its dietary supplement product unbuzzdâ„¢, investigating its effects on alcohol intoxication and alcohol metabolism. Results of ...
placebo-controlled crossover design clinical trial (NCT06505239) of its dietary supplement product unbuzzdâ„¢, investigating its effects on alcohol intoxication and alcohol metabolism. Results of ...
Quantum BioPharma's CEO, Zeeshan Saeed, remarked on the implications of unbuzzdâ„¢ for safer alcohol consumption, noting its ability to lessen intoxication, restore mental alertness, and help consumers ...